Labshake search
Citations for R&D Systems :
551 - 600 of 2678 citations for Respiratory syncytial virus RSV fusion protein exodomain human heterodimeric IgG1 Fc tag recombinant antigen since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Bioengineering 2022Quote: ... or 150 ng/ml recombinant human LOX homolog like 2 (LOXL2, R&D Systems), with media changed every 2-3 days ...
-
bioRxiv - Cell Biology 2022Quote: ... the samples were treated with human recombinant LOXL3 (RhLOXL3, R&D systems, 6069-AO) or LOXL2 (RhLOXL2 ...
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Molecular Biology 2023Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Bioengineering 2024Quote: ... along with 50 ng/ml recombinant human GDNF (R&D Systems, 212-GD-010) were administered for 12 hr ...
-
bioRxiv - Biochemistry 2024Quote: Human recombinant CatA was first activated by following the manufacturer’s instructions (R&D Systems), incubating at 37°C 10 µg/mL CatA with 1 µg/mL CatL in an activation buffer (25 mM MES pH = 6.0 ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Neuroscience 2020Quote: ... while MABs differentiation into myotubes was initiated in the opposite compartments using MAB differentiation medium containing 2% horse serum (Cat N° 16050122) and 1% sodium pyruvate in DMEM/F12 supplemented with 0.01 μg/ml recombinant human agrin protein (R&D Systems, Cat N° 6624-AG-050). At day 21 ...
-
bioRxiv - Developmental Biology 2022Quote: ... Endoderm lineage explants were generated using recombinant activin protein (R&D Systems) at a final concentration of 160 ng/mL in 1XMMR supplemented with 0.1% BSA ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant Mouse IGF-I/IGF-1 Protein (10ng/ml, R&D Systems), Transforming Growth Factor (TGF)β1 (10ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... 1% ITS+premix and 100ng/ml recombinant CCL2 protein (R&D Systems) or 1% BSA for the control were placed on uncoated or Matrigel coated inserts in the upper compartment ...
-
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signallingbioRxiv - Immunology 2023Quote: ... Recombinant proteins were from R&D systems (Bio-Techne Ltd., Abingdon, UK). Heparin dp8 and heparan sulfate used in the bio-layer interferometry (BLI ...
-
bioRxiv - Immunology 2023Quote: ... using either PCSK9 peptides or recombinant mPCSK9/hPCSK9 protein (R&D Systems) as the coating antigen ...
-
bioRxiv - Neuroscience 2023Quote: ... Recombinant IL-1β and TNF-α proteins were from R&D Systems. Human IL-6 ELISA kit was from Life Technologies ...
-
bioRxiv - Immunology 2023Quote: ... moDCs were treated with recombinant galectin-9 protein (AF2045, R&D systems) at a final concentration of 1 µg/ml.
-
bioRxiv - Cancer Biology 2024Quote: ... comprised of recombinant mouse IL-15 protein (R&D Systems, Minneapolis, MN) and recombinant mouse IL-15Ralpha Fc chimera protein (R&D Systems) ...
-
bioRxiv - Cancer Biology 2019Quote: ... IgG1 for αVβ3 (R&D Systems) and IgG2B for the CD44 (BD Pharmingen ...
-
bioRxiv - Developmental Biology 2019Quote: ... mouse IgG1 (R&D systems, 11); mouse IgG2b (R&D systems ...
-
bioRxiv - Immunology 2019Quote: ... cover glasses were coated for 2 h at 37°C with 100 nM recombinant ICAM1-FC (796IC, R&D Systems) and washed 2 times with PBS ...
-
bioRxiv - Cell Biology 2020Quote: ... and 100 ng/ml ALK1-Fc chimera protein (R&D Systems, MN, USA), a soluble chimeric protein consisting of the extracellular part of ALK1 fused to a Fc fragment ...
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng ml−1 of recombinant human TNFα (R&D Systems, 210-TA-020/CF) or a combination of both ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 ng/ml recombinant human NRG1-β 1 (#396-HB, R&D Systems, USA) as described in Poitelon et al ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human versican isoform V3 and lumican were from R&D Systems (Minneapolis, MN, USA). Recombinant human versican protein G1 and G3 domains (ab152303 and ab236178 ...
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Pathology 2019Quote: ... Human recombinant PDGF-BB and TNF-α were purchased from R&D Systems (Minneapolis, MN). TRIzol ...